Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2015 (2015), Article ID 485839, 6 pages
http://dx.doi.org/10.1155/2015/485839
Research Article

The Effects of Simvastatin on Proteinuria and Renal Function in Patients with Chronic Kidney Disease

Division of Nephrology, Department of Medicine, Phramongkutklao Hospital and College of Medicine, Bangkok 10400, Thailand

Received 23 June 2015; Revised 10 September 2015; Accepted 17 September 2015

Academic Editor: Jochen Reiser

Copyright © 2015 Bancha Satirapoj et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. T. James, B. R. Hemmelgarn, and M. Tonelli, “Early recognition and prevention of chronic kidney disease,” The Lancet, vol. 375, no. 9722, pp. 1296–1309, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Satirapoj, O. Supasyndh, N. Mayteedol et al., “Obesity and its relation to chronic kidney disease: a population-based, cross-sectional study of a Thai army population and relatives,” Nephrology, vol. 18, no. 3, pp. 229–234, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. V. M. Campese, “Dyslipidemia and progression of kidney disease: role of lipid-lowering drugs,” Clinical and Experimental Nephrology, vol. 18, no. 2, pp. 291–295, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Satirapoj, O. Supasyndh, N. Mayteedol, A. Chaiprasert, and P. Choovichian, “Metabolic syndrome and its relation to chronic kidney disease in a Southeast Asian population,” Southeast Asian Journal of Tropical Medicine and Public Health, vol. 42, no. 1, pp. 176–183, 2011. View at Google Scholar · View at Scopus
  5. E. S. Schaeffner, T. Kurth, G. C. Curhan et al., “Cholesterol and the risk of renal dysfunction in apparently healthy men,” Journal of the American Society of Nephrology, vol. 14, no. 8, pp. 2084–2091, 2003. View at Google Scholar · View at Scopus
  6. B. Satirapoj, K. W. Bruhn, C. C. Nast et al., “Oxidized low-density lipoprotein antigen transport induces autoimmunity in the renal tubulointerstitium,” American Journal of Nephrology, vol. 35, no. 6, pp. 520–530, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. T. W. Dasari, D. J. Cohen, N. S. Kleiman et al., “Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the evaluation of drug eluting stents and ischemic events registry),” American Journal of Cardiology, vol. 113, no. 4, pp. 621–625, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Sandhu, N. Wiebe, L. F. Fried, and M. Tonelli, “Statins for improving renal outcomes: a meta-analysis,” Journal of the American Society of Nephrology, vol. 17, no. 7, pp. 2006–2016, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Douglas, P. G. O'Malley, and J. L. Jackson, “Meta-analysis: the effect of statins on albuminuria,” Annals of Internal Medicine, vol. 145, no. 2, pp. 117–124, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. G. F. M. Strippoli, S. D. Navaneethan, D. W. Johnson et al., “Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trials,” British Medical Journal, vol. 336, no. 7645, pp. 645–651, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, “KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease,” Kidney International Supplements, vol. 3, pp. 136–150, 2013. View at Google Scholar
  12. P. Cravedi and G. Remuzzi, “Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease,” British Journal of Clinical Pharmacology, vol. 76, no. 4, pp. 516–523, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. W. F. Keane, “The role of lipids in renal disease: future challenges,” Kidney International, Supplement, vol. 57, no. 75, pp. S27–S31, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. C. K. Abrass, “Cellular lipid metabolism and the role of lipids in progressive renal disease,” American Journal of Nephrology, vol. 24, no. 1, pp. 46–53, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Oda and W. F. Keane, “Recent advances in statins and the kidney,” Kidney International Supplements, vol. 56, no. 71, pp. S2–S5, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. V. M. Campese, M. K. Nadim, and M. Epstein, “Are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors renoprotective?” Journal of the American Society of Nephrology, vol. 16, no. 3, supplement 1, pp. S11–S17, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Bianchi, R. Bigazzi, A. Caiazza, and V. M. Campese, “A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease,” American Journal of Kidney Diseases, vol. 41, no. 3, pp. 565–570, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. V. G. Athyros, D. P. Mikhailidis, A. A. Papageorgiou et al., “The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study,” Journal of Clinical Pathology, vol. 57, no. 7, pp. 728–734, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Tonelli, L. Moyé, F. M. Sacks, T. Cole, and G. C. Curhan, “Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease,” Journal of the American Society of Nephrology, vol. 14, no. 6, pp. 1605–1613, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. Heart Protection Study Collaborative Group, “MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial,” The Lancet, vol. 361, no. 9374, pp. 2005–2016, 2003. View at Publisher · View at Google Scholar
  21. J. Shepherd, J. J. P. Kastelein, V. Bittner et al., “Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study,” Clinical Journal of the American Society of Nephrology, vol. 2, no. 6, pp. 1131–1139, 2007. View at Publisher · View at Google Scholar · View at Scopus